These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. The effects of antigenic competition on the efficacy of multivalent footrot vaccines. Schwartzkoff CL; Egerton JR; Stewart DJ; Lehrbach PR; Elleman TC; Hoyne PA Aust Vet J; 1993 Apr; 70(4):123-6. PubMed ID: 8098601 [TBL] [Abstract][Full Text] [Related]
44. [Evaluation of construction and expression shiga toxin2 A-luteinizing hormone releasing hormone recombinant toxin]. Yue Y; Yu XW; Yue YH; Feng SZ; Zhu P; Li HL; Yue J Zhonghua Fu Chan Ke Za Zhi; 2003 Mar; 38(3):154-7, 3-1. PubMed ID: 12816690 [TBL] [Abstract][Full Text] [Related]
45. Functional morphology of testis and its excurrent ducts in rats immunized with synthetic luteinizing hormone releasing hormone conjugated to tetanus toxoid. Upadhyay SN; Alam A; Talwar GP J Reprod Immunol; 1989 Nov; 16(2):151-63. PubMed ID: 2689646 [TBL] [Abstract][Full Text] [Related]
46. Immunization with outer membrane proteins (OprF and OprI) and flagellin B protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa. Hassan R; El-Naggar W; Abd El-Aziz AM; Shaaban M; Kenawy HI; Ali YM J Microbiol Immunol Infect; 2018 Jun; 51(3):312-320. PubMed ID: 28291719 [TBL] [Abstract][Full Text] [Related]
47. Immunochemical characterisation and epitope mapping of a novel fimbrial protein (Pg-II fimbria) of Porphyromonas gingivalis. Ogawa T; Yasuda K; Yamada K; Mori H; Ochiai K; Hasegawa M FEMS Immunol Med Microbiol; 1995 Jun; 11(3):247-55. PubMed ID: 7581276 [TBL] [Abstract][Full Text] [Related]
48. Immunization against luteinizing hormone-releasing hormone fusion proteins does not decrease prostate cancer in the transgenic adenocarcinoma mouse prostate model. Hill RE; de Avila DM; Bertrand KP; Greenberg NM; Reeves JJ Exp Biol Med (Maywood); 2003 Jul; 228(7):818-22. PubMed ID: 12876301 [TBL] [Abstract][Full Text] [Related]
49. Antigenic and immunogenic properties of totally synthetic peptide-based anti-fertility vaccines. Ghosh S; Jackson DC Int Immunol; 1999 Jul; 11(7):1103-10. PubMed ID: 10383943 [TBL] [Abstract][Full Text] [Related]
50. Identification of a gene, pilF, required for type 4 fimbrial biogenesis and twitching motility in Pseudomonas aeruginosa. Watson AA; Alm RA; Mattick JS Gene; 1996 Nov; 180(1-2):49-56. PubMed ID: 8973346 [TBL] [Abstract][Full Text] [Related]
51. Vaccines for control of fertility and hormone dependent cancers. Talwar GP; Singh O; Pal R; Chatterjee N Int J Immunopharmacol; 1992 Apr; 14(3):511-4. PubMed ID: 1618603 [TBL] [Abstract][Full Text] [Related]
52. Identification of two genes with prepilin-like leader sequences involved in type 4 fimbrial biogenesis in Pseudomonas aeruginosa. Alm RA; Mattick JS J Bacteriol; 1996 Jul; 178(13):3809-17. PubMed ID: 8682785 [TBL] [Abstract][Full Text] [Related]
53. Characterization of a five-gene cluster required for the biogenesis of type 4 fimbriae in Pseudomonas aeruginosa. Martin PR; Watson AA; McCaul TF; Mattick JS Mol Microbiol; 1995 May; 16(3):497-508. PubMed ID: 7565110 [TBL] [Abstract][Full Text] [Related]
54. PilS and PilR, a two-component transcriptional regulatory system controlling expression of type 4 fimbriae in Pseudomonas aeruginosa. Hobbs M; Collie ES; Free PD; Livingston SP; Mattick JS Mol Microbiol; 1993 Mar; 7(5):669-82. PubMed ID: 8097014 [TBL] [Abstract][Full Text] [Related]
55. [Study on Construction of Recombinant Bb-pGEX- Liu X; Li WG; Luo GX Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):13-17. PubMed ID: 29737082 [TBL] [Abstract][Full Text] [Related]
56. Genetic characterisation of protective vaccine responses in sheep using multi-valent Dichelobacter nodosus vaccines. Raadsma HW; McEwan JC; Stear MJ; Crawford AM Vet Immunol Immunopathol; 1999 Dec; 72(1-2):219-29. PubMed ID: 10614512 [TBL] [Abstract][Full Text] [Related]
57. Isolation of the gene encoding pilin of Bacteroides nodosus (strain 198), the causal organism of ovine footrot. Elleman TC; Hoyne PA; Emery DL; Stewart DJ; Clark BL FEBS Lett; 1984 Jul; 173(1):103-7. PubMed ID: 6146535 [TBL] [Abstract][Full Text] [Related]
58. Transformation-mediated serogroup conversion of Dichelobacter nodosus. Kennan RM; Dhungyel OP; Whittington RJ; Egerton JR; Rood JI Vet Microbiol; 2003 Mar; 92(1-2):169-78. PubMed ID: 12488080 [TBL] [Abstract][Full Text] [Related]
59. [Construction, expression and refolding of recombinant luteinizing hormone releasing hormone-angiogenin toxin]. Ni ZL; Zhang QH; Qu QY; Lü HL; Fan SY; Cai C Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Aug; 45(8):680-4. PubMed ID: 21055247 [TBL] [Abstract][Full Text] [Related]